Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of $0.20, $0.28 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $10.21 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.